Mojgan Nejad | Antimicrobial Resistance | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

          Mojgan Nejad
Affiliation Michigan State University
Country United States
Scopus ID 36470881200
Documents 55
Citations 1,634
h-index 20
Subject Area Antimicrobial Resistance
Event Global Diseases Research Awards
ORCID 0000-0003-1306-6108

Mojgan Nejad is affiliated with Michigan State University and has established a research profile in antimicrobial resistance through scholarly publications, interdisciplinary collaboration, and scientific contributions. Her documented research metrics and publication record demonstrate sustained academic activity and provide an evidence-based foundation for professional recognition within international research communities.[1]

Abstract

Mojgan Nejad has developed an established academic profile in antimicrobial resistance through peer-reviewed research, scientific collaboration, and contributions to evidence-based healthcare knowledge. Her Scopus-indexed publications, citation performance, and sustained scholarly productivity demonstrate active participation in advancing research within infectious diseases and antimicrobial stewardship. The documented research metrics, including publication output and citation impact, reflect continued engagement with internationally recognized scientific standards. These measurable achievements support academic visibility and provide a credible basis for consideration within the Global Diseases Research Awards while highlighting professional commitment to high-quality scientific investigation and knowledge dissemination.[1]

Keywords

Antimicrobial Resistance, Clinical Research, Infectious Diseases, Evidence-Based Medicine, Global Diseases Research Awards

Introduction

Antimicrobial resistance remains an important global healthcare challenge requiring continuous scientific investigation and multidisciplinary collaboration. Researchers contribute by generating reliable evidence that improves clinical practice, informs public health strategies, and supports responsible antimicrobial use across diverse healthcare environments.[2]

Research Profile

Mojgan Nejad has authored fifty-five Scopus-indexed publications with more than one thousand six hundred citations and an h-index of twenty, reflecting sustained scholarly productivity and measurable research influence within antimicrobial resistance and related healthcare disciplines.[1]

Research Contributions

Her published studies contribute to understanding antimicrobial stewardship, infectious disease management, and evidence-based clinical practice while encouraging collaborative research that supports improved healthcare outcomes through rigorous scientific methodology and internationally accessible scholarly communication.[2]

Publications

The publication portfolio demonstrates consistent participation in peer-reviewed scientific literature indexed by international databases, indicating ongoing engagement with recognized academic publishing standards and contributing to the broader exchange of scientific knowledge within healthcare research.[1]

Research Impact

Citation metrics indicate that the published research has received attention from the scientific community, suggesting scholarly relevance and supporting the continued dissemination of findings that may influence future investigations, healthcare policy, and clinical decision-making processes.[4]

Award Suitability

Based on documented publication metrics, citation performance, institutional affiliation, and research specialization, Mojgan Nejad presents an academic profile aligned with the evaluation principles commonly considered for the Best Researcher Award at the Global Diseases Research Awards.[3]

Conclusion

The available academic evidence demonstrates sustained research productivity, measurable scholarly impact, and continued engagement with antimicrobial resistance research, supporting recognition of Mojgan Nejad as a researcher contributing to internationally visible scientific advancement.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Mojgan Nejad, Author ID 36470881200. Scopus.
    https://www.scopus.com/pages/authors/36470881200
  2. Global Diseases Research Awards. (n.d.). Best Researcher Award Information.
    https://globaldiseases.org/
  3. Kianian, S., Nejad, M., & Hegg, E. L. (2026). Structure–bioactivity relationships in lignins: A multivariate analysis. International Journal of Biological Macromolecules. Advance online publication. https://doi.org/10.1016/j.ijbiomac.2026.153074
  4. Acquah, E. K., Yakubison, E., Schenck, R., & Nejad, M. (2026). Tailoring polyol blends for efficient lignin oxyalkylation toward high-performance soy-lignin polyurethane flexible foams. Journal of Industrial and Engineering Chemistry. Advance online publication.
    https://doi.org/10.1016/j.jiec.2026.04.031
  5. Acquah, E. K., Holmes, D., Dunne, K., Bher, A., Sadrabadi, S. A., Joodaky, A., Auras, R., & Nejad, M. (2025). Synthesis and characterization of lignin‐based polycarbonate polyols for flexible polyurethane foam application. Advanced Sustainable Systems.
    https://doi.org/10.1002/cssc.202502528

Hans Rudolf Pfaendler | Microbiology | Best Researcher Award

Published on by Global Diseases Research

Prof. Dr. Hans Rudolf Pfaendler | Microbiology | Best Researcher Award 

Professor Emeritus | University of Munich | Germany

Prof. Dr. Hans Rudolf Pfaendler is a distinguished researcher and faculty member at Ludwig-Maximilians-Universität München, Germany, with a focus on microbiology and chemical sciences. Over his career, he has authored 35 publications that have collectively garnered 660 citations, reflecting both the quality and impact of his work. His research spans innovative methodologies in microbiology, including the development of the CarbaLux test for detecting carbapenemases and AmpC beta-lactamases, as well as contributions to organic chemistry, such as novel formaldehyde derivatives and vicinal diamination of terminal olefins. Pfaendler has collaborated with a broad network of 46 co-authors, highlighting his commitment to interdisciplinary and international research initiatives. His work has significantly advanced diagnostic techniques and synthetic chemistry, providing tools that are not only academically influential but also societally relevant, particularly in addressing antimicrobial resistance and chemical synthesis challenges. Recognized for both methodological innovation and practical applications, his scholarship bridges fundamental research and translational impact, underlining his standing as a leading figure in his field.

Profiles: Scopus | ORCID

Featured Publications

1. Pfaendler, H. R. (1994). ß-Lactame – ein aktueller Überblick: The Organic Chemistry of β-Lactams. Von G. I. Georg. VCH, Weinheim 1993. 381 S., 39 Abb., 68 Tab., geb., DM 189,-. ISBN 3-527-28188-6. Nachrichten aus Chemie, Technik und Laboratorium, 42(1), 29–30.Pf.

2. Pfaendler, H. R., Hendel, W., & Nagel, U. (1992). Stable Oxapenem-3-Carboxylic Acids – A New Class of β-Lactam Antibiotics. Influence of 2- and 6-Alkyl Substituents. Zeitschrift für Naturforschung B, 47(7–8), 726–732

3. Pfaendler, H., Hartung, R., Golz, G., Schlaf, S., Silvennoinen, G., Polborn, K., & Mayer, P. (2009). A Simple and Efficient Preparation of Novel Formaldehyde Derivatives. Synthesis, 2009(1), 9–16.

4. Pfaendler, H. R. (1990). Robinsonade: „Robert Robinson ‐ Chemist Extraordinary”. Von Trevor I. Williams. Oxford University Press (Clarendon Press Oxford) 1990. 201 S., 13 Fotos, geb. $ 25.00, ISBN 0‐19‐858180‐7. Nachrichten aus Chemie, Technik und Laboratorium, 38(10), 318–319.

5. Pfaendler, H. R., Weishaupt, R., & Meffert, H. (2000). Synthesis and Biological Activities of an α-Methyl and a β-Methyl Carbapenem and the Corresponding Unsubstituted Compound. Bioorganic & Medicinal Chemistry Letters, 10(12), 1417–1420.

Prof. Dr. Hans Rudolf Pfaendler’s work advances the rapid detection and characterization of antimicrobial resistance through innovative diagnostic tools, such as the CarbaLux test for carbapenemases and AmpC beta-lactamases. By enabling faster, more accurate identification of resistant bacterial strains, his research supports improved clinical decision-making, enhances patient outcomes, and informs global strategies to combat antibiotic resistance. This contribution bridges fundamental microbiology with practical healthcare applications, promoting both scientific understanding and societal impact.

Mahfuza Nasrin | Microbiology | Best Researcher Award

Published on by Global Diseases Research

Assoc. Prof. Dr. Mahfuza Nasrin | Microbiology | Best Researcher Award 

Associate Professor | Uttara Adhunik Medical College | Bangladesh

Mahfuza Nasrin is an Associate Professor specializing in antimicrobial resistance and antimicrobial stewardship, with a strong focus on clinical microbiology and infection control. Her research portfolio encompasses the bacteriological profiling of bloodstream, wound, and urinary tract infections, as well as the characterization of antimicrobial susceptibility patterns in Bangladesh. She has contributed to over ten peer-reviewed publications, which have collectively garnered 16 citations, reflecting her growing impact in the field. Nasrin has collaborated with national and international colleagues on studies that map antimicrobial resistance trends across diverse clinical settings, highlighting variations between low-, middle-, and high-income regions and offering critical insights for global public health strategies. Her recent work emphasizes the emerging threat of carbapenem-resistant Enterobacterales and the importance of establishing effective infection prevention and control protocols in tertiary care hospitals. Beyond her research, Nasrin’s contributions advance antimicrobial stewardship and inform clinical decision-making, with tangible societal impact in improving patient outcomes and guiding evidence-based policy in healthcare institutions. She continues to engage in collaborative studies and preprints, demonstrating a commitment to innovation, knowledge dissemination, and the global fight against antimicrobial resistance.

Profiles: Scopus | Google Scholar | ORCID

Featured Publications

1. Nasrin, M., Begum, M. F., Rahman, F., Karim, R., Bhuiyan, M. M., & Nawal, N. (2025). Antibiogram and antimicrobial susceptibility pattern of bacterial isolates from a tertiary care hospital in Dhaka. Archives of Microbiology & Immunology, 9(1), 31–37. Cited: 1

2. Nawal, D. N., Begum, M. F., Nasrin, M., Rahman, F., Karim, R., Alam, M. S., … & Alam, D. M. S. (2025). Bacteriological profile and antibiotic susceptibility pattern of clinical isolates from a tertiary care hospital in Dhaka, Bangladesh. Fortune Journal of Health Sciences, 8, 668–674. Cited: 1

3. Nasrin, M., Begum, F., Sujan, M. J., Barua, H. T., Habib, Z. H., Rizvi, S. M. S., … (2025). Bacterial profile and antimicrobial resistance pattern from different clinical specimens at Uttara Adhunik Medical College Hospital, Dhaka. Preprints. Cited: 1

4. Nasrin, M., Begum, M. F., Karim, R., Alam, M. S., & Rahman, F. (2021). Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among bloodstream infection suspected patients attending in a referral hospital. Bangladesh Journal of Medical Microbiology, 15(2), 5–11. Cited: 6

5. Begum, M. F., Nasrin, M., & Alam, M. S. (2020). Bacteriological profile and antibiotic susceptibility patterns of wound infections at Uttara Adhunik Medical College Hospital, Dhaka. Bangladesh Journal of Medical Microbiology, 14(1), 15–19. Cited: 5

Dr. Mahfuza Nasrin’s work on antimicrobial resistance and bacterial infection profiling advances understanding of pathogen susceptibility patterns in clinical settings, directly informing antibiotic stewardship and public health strategies in Bangladesh and globally. Her research supports evidence-based interventions to combat drug-resistant infections, improving patient outcomes and guiding policy in infectious disease management.